Literature DB >> 10027582

Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy.

A Sato1, L Tarnow, H H Parving.   

Abstract

The increased mortality of patients with diabetic nephropathy is mainly due to cardiovascular disease and end stage renal failure. Left ventricular hypertrophy is an independent risk factor for myocardial ischaemia and sudden death. The aim of our cross-sectional study was to evaluate left ventricular structure and function in Type I (insulin-dependent) diabetic patients with diabetic nephropathy. M-mode and Doppler echocardiography were done on 105 Type I diabetic patients with diabetic nephropathy [61 men, age (means +/- SD) 44+/-9 years, and albuminuria [median(range)] 567(10-8188) mg/24 h, serum creatinine 109 (53-558) micromol/l], and 140 Type I diabetic patients with persistent normoalbuminuria [79 men, 47+/-10 years, urinary albumin excretion rate 8 (0-30) mg/24 h, and serum creatinine 81 (55-121) micromol/l]. Patients with and without nephropathy were comparable with respect to sex, body mass index, and duration of diabetes. Arterial blood pressure was slightly higher in patients with nephropathy: 140/79 +/- 17/9 mm Hg vs 134/78 +/- 15/8 mm Hg, p < 0.01, and the majority of proteinuric patients received antihypertensive drugs, 84 vs 17 %, respectively, p < 0.001. Left ventricular mass index was increased in the nephropathic group (means +/- SD) 100.6+/-23.9 g/m2 compared with the normoalbuminuric group 91.4+/-21.9 g/m2, p = 0.002. Left ventricular hypertrophy was found more often in patients with nephropathy 23 (14-31)% compared with patients with normoalbuminuria 9 (5-14)%, p < 0.005. Diastolic function, assessed by the ratio between the peak diastolic velocity and the peak atrial systolic velocity (E/A ratio) and isovolumic relaxation time, was reduced in patients with vs without nephropathy: 1.17+/-0.29 vs 1.34+/-0.32, and 81.7+/-16.5 vs 74.6+/-14.5, p < 0.001 and p = 0.002, respectively. Systolic function was about the same and normal in both groups. Our study suggests that an increase in left ventricular mass index and a decrease in diastolic function occurs early in the course of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027582     DOI: 10.1007/s001250051116

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Authors:  L Tarnow; P Hildebrandt; B V Hansen; K Borch-Johnsen; H-H Parving
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

2.  Myocardial structure, function, and scar in patients with type 1 diabetes mellitus.

Authors:  Evrim B Turkbey; Jye-Yu C Backlund; Saul Genuth; Aditya Jain; Cuilian Miao; Patricia A Cleary; John M Lachin; David M Nathan; Rob J van der Geest; Elsayed Z Soliman; Chia-Ying Liu; João A C Lima; David A Bluemke
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

3.  Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study.

Authors:  Magnus T Jensen; Peter Sogaard; Henrik U Andersen; Jan Bech; Thomas F Hansen; Søren Galatius; Peter G Jørgensen; Tor Biering-Sørensen; Rasmus Møgelvang; Peter Rossing; Jan S Jensen
Journal:  Diabetologia       Date:  2014-01-22       Impact factor: 10.122

4.  Predictors of early cardiac changes in patients with type 1 diabetes mellitus: An echocardiography-based study.

Authors:  David Šuran; Vojko Kanič; Franjo Naji; Igor Krajnc; Miro Čokolič; Eva Zemljič; Andreja Sinkovič
Journal:  Bosn J Basic Med Sci       Date:  2019-06-18       Impact factor: 3.363

5.  Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria.

Authors:  T Babazono; K Hanai; K Suzuki; Y Kiuchi; A Inoue; M Tanaka; N Tanaka; M Hase; A Ishii; Y Iwamoto
Journal:  Diabetologia       Date:  2006-04-13       Impact factor: 10.122

6.  Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study).

Authors:  Harjit Chahal; Jye-Yu C Backlund; Patricia A Cleary; John M Lachin; Joseph F Polak; Joao A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2012-08-09       Impact factor: 2.778

7.  Early signs of left ventricular dysfunction in adolescents with type 1 diabetes mellitus: the importance of impaired circadian modulation of blood pressure and heart rate.

Authors:  K Karavanaki; G Kazianis; I Konstantopoulos; E Tsouvalas; C Karayianni
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

8.  Left ventricular mass reduction in type 1 diabetic patients with nephropathy.

Authors:  Larry A Weinrauch; Andrew Burger; Ray E Gleason; Annette T Lee; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

9.  Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients.

Authors:  Pilly Chillo; Johnson Lwakatare; Janet Lutale; Eva Gerdts
Journal:  Cardiovasc J Afr       Date:  2012-03-20       Impact factor: 1.167

10.  Comparison of left ventricular mass in normotensive type 2 diabetes mellitus patients with that in the nondiabetic population.

Authors:  Sukamal Santra; Asish Kumar Basu; Pradip Roychowdhury; Ramtanu Banerjee; Pankaj Singhania; Sudhakar Singh; Utpal Kumar Datta
Journal:  J Cardiovasc Dis Res       Date:  2011-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.